Revisiting the ABCs of multidrug resistance in cancer chemotherapy

AK Tiwari, K Sodani, CL Dai… - Current …, 2011 - ingentaconnect.com
The adenosine triphosphate binding cassette (ABC) transporters are one of the largest
transmembrane gene families in humans. The ABC transporters are present in a number of …

Multidrug resistance in haematological malignancies

P Sonneveld - Journal of Internal Medicine, 2001 - Wiley Online Library
Sonneveld P (University Hospital Rotterdam–Dijkzigt, The Netherlands). Multidrug
resistance in haematological malignancies (Internal Medicine in the 21st Century). J Intern …

p53 gene mutation in B-cell chronic lymphocytic leukemia is associated with drug resistance and is independent of MDR1/MDR3 gene expression

S El Rouby, A Thomas, D Costin, CR Rosenberg… - 1993 - ashpublications.org
We studied 53 patients with B-cell chronic lymphocytic leukemia (B-CLL) and found
mutations of the p53 gene in 15%. Patients with p53 gene mutations were found to have an …

Epigenetic changes to the MDR1 locus in response to chemotherapeutic drugs

EK Baker, RW Johnstone, JR Zalcberg, A El-Osta - Oncogene, 2005 - nature.com
The mechanism of action of chemotherapeutic drugs and their ability to induce multidrug
resistance (MDR) are of relevance to cancer treatment. Overexpression of P-glycoprotein …

Generation of a drug resistance profile by quantitation of mdr-1/P-glycoprotein in the cell lines of the National Cancer Institute Anticancer Drug Screen.

M Alvarez, K Paull, A Monks, C Hose… - The Journal of …, 1995 - Am Soc Clin Investig
Identifying new chemotherapeutic agents and characterizing mechanisms of resistance may
improve cancer treatment. The Anticancer Drug Screen of the National Cancer Institute uses …

Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry …

CP Leith, IM Chen, KJ Kopecky, FR Appelbaum… - 1995 - ashpublications.org
Resistance to chemotherapy is a major factor limiting successful treatment of acute myeloid
leukemia (AML); one of the best characterized drug resistance mechanisms is extrusion of …

Acute myelogenous leukaemia in the elderly: retrospective study of 235 consecutive patients

M Baudard, JP Marie, M Cadiou… - British journal of …, 1994 - Wiley Online Library
A retrospective analysis was performed on 235 elderly acute myelogenous leukaemia (AML)
patients aged 60 years or more, consecutively admitted to a single haematological …

Predominance of functional multidrug resistance (MDR-1) phenotype in CD34+ acute myeloid leukemia cells

PA Te Boekhorst, K de Leeuw, M Schoester, S Wittebol… - 1993 - ashpublications.org
The expression of the MDR-1-encoded P-170 glycoprotein (P-170) associated with clinical
multidrug resistance (MDR) was investigated in 52 consecutive patients with untreated acute …

The network of P‐glycoprotein and microRNAs interactions

V Lopes‐Rodrigues, H Seca, D Sousa… - … journal of cancer, 2014 - Wiley Online Library
Overexpression of P‐glycoprotein (P‐gp) contributes to the multidrug resistance (MDR)
phenotype found in many cancer cells. P‐gp has been identified as a promising molecular …

Clinical relevance of P-glycoprotein expression in de novo acute myeloid leukemia

G Del Poeta, R Stasi, G Aronica, A Venditti, MC Cox… - 1996 - ashpublications.org
Cytofluorimetric detection of the multidrug resistance (MDR)-associated membrane protein
(P-170) was performed at the time of diagnosis in 158 patients with acute myeloid leukemia …